Evidence map›Paper›PMID 40831853›Full record

ArticleCureus2025

Valproic Acid Causes Extensive Cell Detachment and Death in Differentiated Sh-SY5Y Cell Cultures: An In Vitro Observation.

Ioannis Dardalas, Roza Lagoudaki, Efstratios K Kosmidis, Vasilios Kimiskidis, Theodoros Moysiadis, Dimitrios Kouvelas, Chryssa Pourzitaki

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ioannis DardalasLaboratory of Clinical Pharmacology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, GRC.
Roza LagoudakiLaboratory of Physiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, GRC.
Efstratios K KosmidisLaboratory of Physiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, GRC.
Vasilios KimiskidisLaboratory of Clinical Neurophysiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, GRC.
Theodoros MoysiadisDepartment of Computer Science, School of Sciences and Engineering, University of Nicosia, Nicosia, CYP.
Dimitrios KouvelasLaboratory of Clinical Pharmacology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, GRC.
Chryssa PourzitakiLaboratory of Clinical Pharmacology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, GRC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction Valproic acid (VA) has been a widely used drug in the management of epilepsy, migraine headaches, and bipolar disorder for many decades. Recently, the drug has been tested in various types of malignancy, showing promising results. Despite its well-established effectiveness, there are certain safety concerns that should be taken into consideration. VA has been classified as teratogenic and should be avoided during pregnancy. Methods This study was designed in order to present the effects of valproate on differentiated SH-SY5Y cell cultures and their concentration dependency. SH-SY5Y cells were differentiated into a mature neuron-like phenotype and then treated with VA at either 1 mM or 10 mM. Morphological criteria were compared between treated and untreated cells, serving as a control for identification. Results It was observed that VA consistently induces extensive detachment of the adherent cells and cell death. At a concentration of 1 mM, a 44,0% reduction of adherent cells was observed, while at a concentration of 10 mM, the reduction was 95.9%. Conclusion VA causes extensive cell detachment and death in differentiated SH-SY5Y cell cultures. There is a paucity of studies on these effects, which underlines the importance of further and more extensive research on this matter.

Indexed as

in vitroneurotoxicitysh-sy5yvalproatevalproic acid

Identifiers

PMID40831853
PMCPMC12359114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.